Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jette van Lint"'
Autor:
Barbara Bergmans, Naomi Jessurun, Jette van Lint, Jean-Luc Murk, Eugène van Puijenbroek, Esther de Vries
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0296821 (2024)
IntroductionBiologicals have become a cornerstone in rheumatoid arthritis (RA) treatment. The increased risk of serious infections associated with their use is well-established. Non-serious infections, however, occur more frequently and are associate
Externí odkaz:
https://doaj.org/article/b2165fb8d128465bb58407eff2e93300
Autor:
Bergmans, Barbara1,2 (AUTHOR) b.j.m.bergmans@tilburguniversity.edu, Jessurun, Naomi3 (AUTHOR), van Lint, Jette3 (AUTHOR), Murk, Jean-Luc2,4 (AUTHOR), van Puijenbroek, Eugène3,5 (AUTHOR), de Vries, Esther1,2 (AUTHOR)
Publikováno v:
PLoS ONE. 2/20/2024, Vol. 19 Issue 2, p1-16. 16p.
Publikováno v:
Annals of the Rheumatic Diseases; 2022 Supplement, Vol. 81, p453-1135, 683p
Publikováno v:
Annals of the Rheumatic Diseases; 2022 Supplement, Vol. 81, p1136-1892, 757p
Publikováno v:
Annals of the Rheumatic Diseases; 2021 Supplement, Vol. 80, p401-1035, 635p
Publikováno v:
Annals of the Rheumatic Diseases; 2021 Supplement, Vol. 80, p1036-1485, 450p
Autor:
H. Gosselt, J. Van Lint, S. Tas, B. Van den Bemt, H. Vonkeman, F. Hoentjen, M. Nurmohamed, M. Van Doorn, N. Jessurun
Publikováno v:
Annals of the Rheumatic Diseases. 81:595-596
BackgroundWomen generally report more adverse drug reactions (ADRs) than men. Information on sex differences concerning the frequency and the nature of ADRs is still limited and sex differences are often not considered in research on ADRs. Consequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a63b74521fcf778bdbb270b8123f78ca
https://doi.org/10.1136/annrheumdis-2022-eular.2614
https://doi.org/10.1136/annrheumdis-2022-eular.2614
Autor:
M. Ophoff, J. Van Lint, S. Tas, B. Van den Bemt, H. Vonkeman, F. Hoentjen, M. Nurmohamed, N. Jessurun
Publikováno v:
Annals of the Rheumatic Diseases. 81:1127.1-1128
BackgroundSelf-management strategies of adverse drug reactions (ADRs) are outside the vision of healthcare professionals (HCPs). Nevertheless, patients consider this information as one of the most important domains regarding ADR information (1). Ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::434eb74bad970934a3f5a703eea47a71
https://doi.org/10.1136/annrheumdis-2022-eular.2682
https://doi.org/10.1136/annrheumdis-2022-eular.2682
Autor:
H. Gosselt, J. Van Lint, L. Kosse, S. Tas, P. Spuls, H. Vonkeman, M. Nurmohamed, M. Van Doorn, B. Van den Bemt, N. Jessurun
Publikováno v:
Annals of the Rheumatic Diseases. 81:1111.1-1111
BackgroundPatients experience burden of adverse drug reactions.1 So far, it is not known whether men and women experience adverse drug reactions (ADRs) with the same burden.ObjectivesTo examine sex differences in regard to the burden of mutually repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a91a7fd6e1279f9181e7dcc0bcc8b453
https://doi.org/10.1136/annrheumdis-2022-eular.2787
https://doi.org/10.1136/annrheumdis-2022-eular.2787
Autor:
M.B.A. van Doorn, Frank Hoentjen, E P van Puijenbroek, B. van den Bemt, F. Van Hunsel, Renske C. F. Hebing, Sander W. Tas, Michael T. Nurmohamed, J. Van Lint, Naomi T Jessurun, Harald E. Vonkeman
Publikováno v:
Annals of the Rheumatic Diseases. 80:578-579
Background:Janus kinase (JAK) inhibitors are effective small molecular drugs for rheumatoid arthritis (RA) and other immune mediated inflammatory diseases (IMIDs). JAK inhibitors exert their immunosuppressive effects by suppressing the action of JAK,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::427d1e47a300d13a4d2a6272b4f0ca37
https://doi.org/10.1136/annrheumdis-2021-eular.1851
https://doi.org/10.1136/annrheumdis-2021-eular.1851